Skip to main content

Advertisement

SpringerLink
Log in

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Harashima N (2004) Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64:391–399

    Article  CAS  PubMed  Google Scholar 

  2. Takamori A, Hasegawa A, Utsunomiya A et al (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8:100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Suehiro Y, Hasegawa A, Iino T et al (2015) Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br J Haematol 169:356–367

    Article  CAS  PubMed  Google Scholar 

  4. Sugiyama D, Nishikawa H, Maeda Y, et al (2013) Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A 110:17945–17950.

  5. Sugata K, Yasunaga J-I, Miura M et al (2016) Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep 6:27150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fukushima T, Nomura S, Shimoyama M et al (2014) Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166:739–748

    Article  PubMed  Google Scholar 

  7. Ishida T, Jo T, Takemoto S et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672–682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ureshino H, Shindo T, Nishikawa H et al (2016) Effector regulatory T cells reflect the equilibrium between antitumor immunity and autoimmunity in adult T-cell leukemia. Cancer Immunol Res 4:644–649

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan

    Hiroshi Ureshino

  2. Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan

    Hiroshi Ureshino, Kazuharu Kamachi & Masaharu Miyahara

Authors
  1. Hiroshi Ureshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuharu Kamachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaharu Miyahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to patient care and wrote the report. Informed consent was obtained from the patient for publication of this case report.

Corresponding author

Correspondence to Hiroshi Ureshino.

Ethics declarations

Author’s disclosures of conflicts of interest

The authors declare no potential conflicts of interest (COI).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ureshino, H., Kamachi, K. & Miyahara, M. Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients. Ann Hematol 96, 1587–1588 (2017). https://doi.org/10.1007/s00277-017-3052-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3052-4

Search

Navigation